Shimal Research Laboratories Limited

Shimal Research Laboratories Limited - pharma in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U73100DL2001PLC109185 Incorporated 12 January 2001 ROC Delhi HQ New Delhi, Delhi, India
Pending Strike Off Public Limited Company pharma
Data last updated
Revenue · FY 2016
₹4,000
▼ 99.62% YoY
EBITDA · FY 2016
*****
▼ 392.54% YoY
Net profit · FY 2016
*****
▼ 463.98% YoY
Authorised capital
₹40 Cr
Registered with MCA
Paid-up capital
₹37.49 Cr
Issued & subscribed
Open charges
None
Secured borrowings
Company age
25 yrs
Est. 2001
Last financials
Mar 2018
Balance sheet date

About Shimal Research Laboratories Limited

Data last updated: 25 July 2025

Shimal Research Laboratories Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of Oscar Investments Limited. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 12 January 2001, the company has been in operation for over 25 years.

Registered with ROC Delhi under CIN U73100DL2001PLC109185.

Capital: an authorised share capital of ₹40 Cr and a paid-up capital of ₹37.49 Cr. It is led by directors including Pradeep Kumar Shukla and Prakash Mishra.

Last AGM: 27 September 2018. Financial statements filed for year ended 31 March 2018. Office: G – 16 Marina Arcade Connaught Circus, New Delhi, Delhi, India – 110001.

As per the financials filed for FY 2016, the company reported a revenue of ₹4,000, a decline of 99.62% compared to the previous year.

It operates as a subsidiary of Oscar Investments Limited. Its group structure includes 1 subsidiary.

The company is under the process of being struck off by the Registrar of Companies. This typically indicates non-filing of statutory returns, and the company may soon cease to exist as a legal entity.

Company Details of Shimal Research Laboratories Limited
CIN U73100DL2001PLC109185
Registration Number 109185
Incorporation Date 12 January 2001
ROC Delhi
Listing Status Unlisted
Company Status Under Process of Striking Off
Date of Last AGM 27 September 2018
Date of Balance Sheet 31 March 2018
Parent Company Oscar Investments Limited
Compliance Status Active Non-Compliant
Key People
Pradeep Kumar Shukla Director Prakash Mishra Director Sanjeev Kumar Singhal Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    G – 16 Marina Arcade Connaught Circus, New Delhi, Delhi, India – 110001
  • Industry
    Pharma, Pharma Contract R&D
Company report
Shimal Research Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Shimal Research Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Shimal Research Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Shimal Research Laboratories Limited

Shimal Research Laboratories Limited has one previous CIN (Corporate Identification Number): U73100DL2001PTC109185. The current CIN is U73100DL2001PLC109185, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U73100DL2001PLC109185 Current
U73100DL2001PTC109185 Previous

Business Activity of Shimal Research Laboratories Limited

Shimal Research Laboratories Limited operates primarily in the hospital and medical care sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
********* Hospital and Medical Care ********* Other Hospital and Medical Care Activities *********

Auditor Details of Shimal Research Laboratories Limited

Shimal Research Laboratories Limited is audited by S R BAGAI & CO for the financial year 2016. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
S R BAGAI & CO blur-value blur-value blur-value

Board of Directors of Shimal Research Laboratories Limited

Shimal Research Laboratories Limited is currently managed by 3 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Pradeep Kumar Shukla Director 02 Apr 2018 8 Years 3 Months Current
Prakash Mishra Director 27 Aug 2018 7 Years 10 Months Current
Sanjeev Kumar Singhal
Also directs: Anr Securities Private Limited
Director 28 Nov 2011 14 Years 7 Months Current
View all directors

Financials of Shimal Research Laboratories Limited FY 2018 filings available

Shimal Research Laboratories Limited reported revenue of ₹- (down -99.62% YoY) for FY 2016. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue
- ▼ -99.62%
Profit
***** ▼ -463.98%
EBITDA
***** ▼ -392.54%
Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****

Consolidated Statements

Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.

Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Shareholding Pattern of Shimal Research Laboratories Limited

As of FY 2017, Shimal Research Laboratories Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.

2025
YEAR
38.19% Promoters
25.22% DII (Domestic Institutional)
10.28% FII (Foreign Institutional)
25.89% Public
2.42% Others
Shareholding Trend
Year 2025
Promoters 33.19%
DII 23.22%
FII 18.28%
Public 22.89%
Others 2.42%

Group Structure of Shimal Research Laboratories Limited

Shimal Research Laboratories Limited has 1 subsidiary company. This group structure data is as of FY 2017. The corporate group structure reflects Shimal Research Laboratories Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Fortis Clinical Research Limited U73100DL2005PLC134482
**.**%

Showing major subsidiaries. Total: 1.

Charges & Borrowings Shimal Research Laboratories Limited

Shimal Research Laboratories Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Shimal Research Laboratories Limited

View historical data on people associated with Shimal Research Laboratories Limited, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Shimal Research Laboratories Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Shimal Research Laboratories Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Shimal Research Laboratories Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Shimal Research Laboratories Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Shimal Research Laboratories Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Shimal Research Laboratories Limited

MSME Payment Delays by Shimal Research Laboratories Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Shimal Research Laboratories Limited

Subsidiaries & Group Companies of Shimal Research Laboratories Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Shimal Research Laboratories Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Shimal Research Laboratories Limited

MCA Filings & Documents of Shimal Research Laboratories Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Shimal Research Laboratories Limited

Activity
27 Sep 2018
Shimal Research Laboratories Limited last Annual general meeting of members was held on 27 Sep 2018 as per latest MCA records.
Directors
27 Aug 2018
Prakash Mishra was appointed as a Director on 27 Aug 2018 & has been associated with this company since 7 years 10 months.
Directors
02 Apr 2018
Pradeep Kumar Shukla was appointed as a Director on 02 Apr 2018 & has been associated with this company since 8 years 3 months.
Activity
31 Mar 2018
Shimal Research Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi.
Directors
28 Nov 2011
Sanjeev Kumar Singhal was appointed as a Director on 28 Nov 2011 & has been associated with this company since 14 years 7 months.
Activity
12 Jan 2001
Shimal Research Laboratories Limited was registered on 12 Jan 2001 with Roc Delhi & aged 25 years 6 months as per MCA records.

Frequently Asked Questions about Shimal Research Laboratories Limited

Shimal Research Laboratories Limited is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.

Shimal Research Laboratories Limited is a company pending strike off, currently registered as a public limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 12 January 2001 and is registered under CIN U73100DL2001PLC109185. The company may be struck off soon - caution is advised.

The compliance status of Shimal Research Laboratories Limited is active non-compliant as of 25 July 2025.

The current directors of Shimal Research Laboratories Limited are:

The CIN (Corporate Identification Number) of Shimal Research Laboratories Limited is U73100DL2001PLC109185. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Shimal Research Laboratories Limited is pharma. The company specifically operates in pharma contract r and d.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available